Literature DB >> 18855639

Acute phase proteins in atherosclerosis (acute coronary syndrome).

Michele Correale1, Natale Daniele Brunetti, Luisa De Gennaro, Matteo Di Biase.   

Abstract

Investigation of the mechanisms of atherosclerosis has determined that inflammation plays a central role in the development, progression, and outcome of acute coronary syndrome (ACS). C-reactive protein (CRP) plasma levels increase in patients with ACS. CPR is an important prognostic marker in ACS, following angioplasty, and in the long-term management of post-infarction patients. Although CRP will remain over time a useful marker, the role and implications of increased plasma concentrations of other acute phase proteins (APPs), such as alpha-1-antitrypsin (A1AT), alpha-1 glycoprotein (A1GP), haptoglobin (HG), ceruloplasmin (CP), and C3c and C4 complement fraction, in patients with ACS are still not completely defined. This short review summarizes the experimental and clinical evidence regarding the role, and the biological and clinical significance of these other APPs in ACS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855639     DOI: 10.2174/187152508785909537

Source DB:  PubMed          Journal:  Cardiovasc Hematol Agents Med Chem        ISSN: 1871-5257


  16 in total

1.  Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.

Authors:  W H Wilson Tang; Yuping Wu; Jaana Hartiala; Yiying Fan; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Paul L Fox; Hooman Allayee; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

2.  Age- and Sex-Associated Effects on Acute-Phase Proteins in Göttingen Minipigs.

Authors:  Berit Ø Christoffersen; Søren J Jensen; Trine P Ludvigsen; Sara K Nilsson; Anette B Grossi; Peter M H Heegaard
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

3.  Increased serum levels of interleukin-6 and von Willenbrand Factor in early phase of acute coronary syndrome in a young and multiethnic Malaysian population.

Authors:  Wen Ni Tiong; Alan Yean Yip Fong; Edmund Ui Hang Sim; Hiang Chuan Chan; Tiong Kiam Ong; Boon Cheng Chang; Kui Hian Sim
Journal:  Heart Asia       Date:  2012-10-16

Review 4.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

5.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Jacek Karpe; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2009-12-11       Impact factor: 3.984

6.  Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms.

Authors:  Kazumi Satoh; Tomoko Maniwa; Teiji Oda; Ken-Ichi Matsumoto
Journal:  Proteome Sci       Date:  2013-06-27       Impact factor: 2.480

7.  Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years.

Authors:  Elide Anna Pastorello; Laura Farioli; Laura Michelina Losappio; Nuccia Morici; Matteo Di Biase; Michele Nichelatti; Jan Walter Schroeder; Luca Balossi; Silvio Klugmann
Journal:  Clin Mol Allergy       Date:  2015-06-02

Review 8.  Surgical inflammatory stress: the embryo takes hold of the reins again.

Authors:  Maria-Angeles Aller; Jose-Ignacio Arias; Isabel Prieto; Carlos Gilsanz; Ana Arias; Heping Yang; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2013-02-01       Impact factor: 2.432

9.  Ceruloplasmin and the extent of heart failure in ischemic and nonischemic cardiomyopathy patients.

Authors:  Yifei Xu; Haiyan Lin; Ying Zhou; Gang Cheng; Geng Xu
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

10.  Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy.

Authors:  Ahmed A Elmarakby; Rafik Abdelsayed; Jun Yao Liu; Mahmood S Mozaffari
Journal:  EPMA J       Date:  2010-03-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.